Identification and assessment of endocrine disrupters: Limitations of in vivo and in vitro assays

Environmental Health Perspectives

Volumn 106, Issue SUPPL. 2, 1998, Pages 577-582

  Zacharewski, Tim ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Michigan State University   (United States)

Author keywords

Androgen; Endocrine disrupter; Estrogen; In vivo and in vitro testing

Indexed keywords

ANDROGEN; ESTROGEN;

CANCER; CONFERENCE PAPER; ENDOCRINE SYSTEM; EUROPE; GENITAL SYSTEM; HUMAN; NONHUMAN; NORTH AMERICA; PRIORITY JOURNAL; REPRODUCTION; TOXICITY TESTING; WILDLIFE;

EID: 0031804204     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106577     Document Type: Conference Paper

References (123)

1. Adami H, Bergstrom R, Mohner M, Zatonski W, Storm H, Ekbom A, Tretli S, Teppo L, Ziegler H, Rahu M. Testicular cancer in nine northern European countries. Int J Cancer 59:33-38 (1994).
2. Ahlborg UG, Lipworth L, Titus-Ernstoff L, Hsieh C-C, Hanberg A, Baron J, Trichopoulos D, Adami H-O. Organochlorine compounds in relation to breast cancer, endometrial cancer and endometriosis: an assessment of the biological and epidemiological evidence. Grit Rev Toxicol 25:463-531 (1995).
3. Forman D, Moller H. Testicular cancer. Cancer Surv 19/20:323-341 (1994).
4. Giwercman A, Skakkebaeck NE. The human testis - an organ at risk. Int J Androl 15:373-375 (1992).
5. Houghton DL, Ritter L. Organochlorine residues and risk of breast cancer. J Am Coll Toxicol 14:71-89 (1995).
6. Spitz MR, Sieder JG, Pollack ES, Lynch HK, Newell GR. Incidence and descriptive features of testicular cancer among United States whites, blacks and Hispanics. Cancer 58:1785-1790 (1986).
7. Osterlind A. Diverging trends in incidence and mortality of testicular cancer in Denmark, 1943-1982. Br J Cancer 53:501-505 (1986).
8. Wilkinson TJ, Colls BM, Schhluter PJ. Increased incidence of germ cell testicular cancer in New Zealand Maoris. Br J Cancer 65:769-771 (1992).
9. Newman PA. Breast cancer incidence is on the rise - but why? (News Report). J Natl Cancer Inst 82:998-1000 (1990).
10. Glass AG, Hoover RN. Rising incidence of breast cancer: relationship to stage and receptor status. J Natl Cancer Inst 82:693-696 (1990).
11. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for decreasing quality of semen during past 50 years. Br Med J 305:609-613 (1992).
12. Colborn T, vom Saal FS, Soto AM. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 101:378-384 (1993).
13. Giesy JP, Ludwig JP, Tillitt DE. Deformities in birds of the Great Lakes Region. Assigning causality. Environ Sci Technol 28:128A-135A (1994).
14. Jackson MB. The epidemiology of cryptorchidism. Hormone Res 30:153-156 (1988).
15. Sharps RM. Another DDT connection. Nature 375:538-539 (1995).
16. Willet W. The search for the causes of breast and colon cancer. Nature 338:389-394 (1989).
17. Arai Y, Mori T, Suzuki Y, Bern HA. Long-term effects of perinatal exposure to sex steroids and diethylstilbestrol on the reproductive system of male mammals. Int Rev Cytol 84:235-268 (1983).
18. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 284:878-881 (1971).
19. Prener A, Hsieh C-C, Engholm G, Trichopoulos D, Jensen OM. Birth order and risk of testicular cancer. Cancer, Causes, Control 3:265-272 (1992).
20. Welsch CW. Hormones and murine mammary tumorgenesis: an historical view. In: Hormonal Regulation of Mammary Tumors (Leung BS, ed). Montreal:Eden Press, 1982;1-29.
21. Depue RH. Maternal and gestational factors affecting the risk of cryptorchidism and inguinal hernia. Int J Epidemiol 13:311-318 (1984).
22. Henderson BE, Ross R, Bernstein L. Estrogens as a cause of human cancer. Cancer Res 48:246-253 (1988).
23. Vessey MP. The involvement of estrogen in the development and progression of breast disease: epidemiological evidence. Proc R Soc Edinb 95B:35-48 (1989).
24. McLachlan JA, Newbold RR, Bullock B. Reproductive tract lesions in male mice prenatally exposed to diethylstilbestrol. Science 190:991-992 (1975).
25. McLachlan JA. Prenatal exposure to diethylstilbestrol in mice; toxicological studies. J Toxicol Environ Health 2:527-577 (1977).
26. Miller WR. Endocrine treatment for breast cancers: biological rationale and current progress. J Steroid Biochem Molec Biol 37:467-480 (1990).
27. Santen RJ, Manni A, Harvey H, Redmond C. Endocrine treatment of breast cancer in women. Endocr Rev 11:221-265 (1990).
28. Carter HB, Coffey DS. The prostate: an increasing medical problem. Prostate 16:39-48 (1990).
29. Chiarodo A. National Cancer Institute roundtable on prostate cancer: future research directions. Cancer Res 51:2498-2505 (1991).
30. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101:372-377 (1993).
31. Davis DL, Bradlow HL, Can environmental estrogens cause breast cancer? Sci Am (October):167-172 (1995).
32. Falck F, Ricci A, Wolff MS, Godbold J, Deckers P. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 47:143-146 (1992).
33. Hileman B. Environmental estrogens linked to reproductive abnormalities, cancer. Chem Eng News 31:19-23 (1994).
34. Sharpe RM, Skakkebaek NE. Are estrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341:1392-1395 (1993).
35. Wolff MS, Toniolo PG, Lee EW, Rivera M, Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85:648-652 (1993).
36. Martin PM, Horwitz KB, Ryan DS, McGuire WL. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 103:1860-1867 (1978).
37. Miksicek RJ. Commonly occurring plant flavonoids have estrogenic activity. Mol Pharmacol 44:37-43 (1993).
38. verdeal K, Ryan D. Naturally-occurring estrogens in plant foodstuffs: a review. J Food Prot 42:577-583 (1979).
39. McLachlan JA, Korach KS, Newbold RR, Degen GH. Diethylstilbestrol and other estrogens in the environment. Fundam Appl Toxicol 4:686-691 (1984).
40. Clemons JH, Marvin CR, Wu ZF, McCarry BE, Allan L, Bryant DW, Zacharewski TR. Identification of estrogen- and dioxin-like activities in urban air particulate matter using recombinant receptor/reporter gene bioassays. In: 17th Annual Meeting of the Society of Environmental Toxicology and Chemistry, 17-21 November 1996, Washington, DC. Abstract 490. Pensacola, FL:SETAC Press, 1996;211.
41. Fielden M, Wu ZF, Chen I, Chittim B, Safe S, Zacharewski T. Examination of the estrogenicity of 2,2',4,6,6'-pentachlorobiphenyl (PCB104) and its hydroxylated and chlorinated derivatives, 2,2',4,6,6-pentachloro-4-biphenylol and 2,2',4,4',6,6'-hexachlorobiphenyl (PCB155). Toxicol Appl Pharmacol (Suppl) 36:159 (810) (1997).
42. Jansen HT, Cooke PS, Porcelli J, Liu T-C, Hansen LG. Estrogenic and antiestrogenic actions of PCBs in the female rat: in vitro and in vivo studies. Reprod Toxicol 7:237-248 (1993).
43. Kelce WR, Stone CR, Laws SC, Gray LE, Kemppalnen JA, Wilson EM. Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist. Nature 375:581-585 (1995).
44. Safe S. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Pharmacol Ther 67:247-281 (1995).
45. Korach K. Editorial: Surprising places of estrogenic activity. Endocrinology 132:2277-2278 (1993).
46. Krishnan AV, Stathis P, Permuth SF, Tokes L, Feldman D. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132:2279-2286 (1993).
47. Nimrod AC, Benson WH. Environmental estrogenic effects of alkylphenol ethoxylates. Crit Rev Toxicol 26:335-364 (1996).
48. Wilcox AJ, Baird DD, Weinberg CR, Hornsby PP, Herbst AL. Fertility in men exposed prenatally to diethylstilbestrol. N Engl Med 332:1411-1416 (1995).
49. Fisch H, Goluboff ET, Olson JH, Feldshuh J, Broder SJ, Barad DH. Semen analyses in 1,283 men from the United States over a 25-year period: no decline in quality. Fertil Steril 65:1009-1014 (1996).
50. Fisch H, Goluboff ET. Geographic variation in sperm counts: a potential cause of bias in studies of semen quality. Fertil Steril 65:1044-1046 (1996).
51. Paulsen CA, Berman NG, Wang C. Data from men in greater Seattle area reveals no downward trend in semen quality: further evidence that deterioration of semen quality is not geographically uniform. Fertil Steril 65:1015-1020 (1996).
52. Adtercreutz H, Fotsis T, Heikkinen R, Dwyer JT, Woods M, Goldin BR, Gorbach SL. Excretion of the lignans enterolactone and enterodiol and of equol in omniverous and vegetarian women and women with breast cancer. Lancet 11:1295-1299 (1982).
53. Messina MJ, Persky V, Setchell KDR, Barnes S. Soy intake and cancer risk: a review of in vitro and in vivo data. Nutr Cancer 21:113-131 (1994).
54. Barnes S, Grubbs C, Setchell KDR, Carlson J. Soybeans inhibit mammary tumors in models of breast cancer. In: Mutagens and Carcinogens in the Diet (Pariza M, ed). New York:Wiley-Liss, 1990;239-253.
55. Hirano T, Fukuoka K, Oka K, Naito T, Hosaka K, Mitsuhashi H, Matsumoto Y. Antiproliferative activity of mammalian lignan derivatives against the human breast cell line, ZR-75-1. Cancer Invest 8:595-601 (1990).
56. Safe SH. Environmental and dietary estrogens and human health: is there a problem? Environ Health Perspect 103:346-351 (1995).
57. ECETOC. ECETOC Document 33 "Environmental Oestrogens". Compendium of Test Methods 33. Brussels: European Centre for Ecotoxicology and Toxicology of Chemicals, 1997.
58. Reel JR, Lamb JC, Neal BH. Survey and assessment of mammalian estrogen biological assays for hazard characterization. Fundam Appl Toxicol 34:288-305 (1996).
59. Zacharewsld T. In vitro assays used to assess estrogenic substances. Environ Sci Tech 31:613-623 (1997).
60. Hammond GL. Molecular properties of corticoid binding globulin and the sex-steroid binding proteins. Endocr Rev 11:65-79 (1990).
61. Lans MC, Klasson-Wehler E, Willemsen M, Meussen E, Safe S, Brouwer A. Structure-dependent, competitive interaction of hydroxy-polychlorobiphenyls, -dibenzo-p-dioxins and -dibenzofurans with human transthyretin. Chem-Biol Interact 88:7-21 (1993).
62. Khalil MW, Morley P, Glasier MA, Armstrong DT, Lang T. Formation of 4-oestrone-3,17-dione (19-norandrostenedione) by porcine granulosa cells in vitro is inhibited by the aromatase inhibitor 4-hydroxyandrostenedione and the cytochrome P-450 inhibitors aminoglutethimide phosphate and ketoconazole. J Endocrinol 120:251-260 (1989).
63. Pappas TC, Gametchu B, Watson CS. Membrane estrogen receptors identified by multiple antibody labelling and impeded-ligand binding. FASEB J 9:404-410 (1995).
64. Watson CS, Pappas TC, Gametchu B. The other estrogen receptor in the plasma membrane: implications for the action of environmental estrogens. Environ Health Perspect 103 (Suppl 7):41-50 (1996).
65. Dorfman RI, Dorfman AS. Estrogen assays using the rat uterus. Endocrinology 55:65-69 (1954).
66. Hisaw FL. Comparative effectiveness of estrogens on fluid imbibition and growth of the rat's uterus. Endocrinology 54:276-289 (1959).
67. Jones RC, Edgren RA. The effects of various steroids on the vaginal histology in the rat. Fertil Steril 24:284-291 (1973).
68. Lauson HD, Heller CG, Golden JB, Sevringhaus EL. The immature rat uterus in the assay of estrogenic substances and a comparison of estradiol, estrone and estriol. Endocrinology 24:35-44 (1939).
69. Martin L, Claringbold PJ. The mitogenic action of oestrogens in the vaginal epithelium of the ovariectomized mouse. J Endocrinol 20:173-186 (1960).
70. Rubin BL, Dorfman AS, Black L, Dorfman RI. Bioassay of estrogens using the mouse uterine response. Endocrinology 49:429-439 (1951).
71. Astwood EB. Estrogens and progestins. In: The Pharmacological Basis of Therapeutics. 4th Ed (Goodman LS, Gilamn A, eds). Toronto:The MacMillan Company, 1970;1538-1565.
72. Gellert RJ. Kepone, mirex, dieldrin and aldrin: estrogenic activity and the induction of persistent vaginal estrus and anovulation in rats following neonatal treatment. Environ Res 16:131-138 (1978).
73. Clark JH, Watson C, Upchurch S, McCormack S, Padykula H, Markaverich B, Hardin JW. Estrogen action in normal and abnormal cell growth. In: Estrogens in the Environment (McLachlan JA, ed). New York:Elsevier, 1980;53-67.
74. Drill VA. Endocrine properties and long-term safety of oral contraceptives. Metabolism 14:295-301 (1965).
75. Emmens CW, Martin L. Estrogens. In: Methods in Hormone Research, Vol III (Dorfman RI, ed). New York:Academic Press, 1964;1-80.
76. Korach KS, McLachlan JA. Techniques for detection of estrogenicity. Environ Health Perspect 103 (Suppl 7):5-8 (1995).
77. Nelson JA, Struck RF, James R. Estrogenic activities of chlorinated hydrocarbons. J Toxicol Environ Health 4:325-339 (1978).
78. Drill VA. Biological properties. In: Oral Contraceptives. New York:Mcgraw-Hill, 1966;16-43.
79. Terenius L. The Allen-Doisy test for estrogens reinvestigated. Steroids 17:653-661 (1971).
80. Rosner W. The functions of corticoid-binding globulin and sex hormone-binding globulin: recent advances. Endocr Rev 11:80-91 (1990).
81. Strel'chyonok OA, Avvakumov GV. Specific steroid-binding glycoproteins of human blood plasma: novel data on their structure and function. J Steroid Biochem 35:519-534 (1990).
82. Fortunati N, Fissore F, Fazzari A, Berta L, Giudici M, Frairia R. Sex steroid-binding protein interacts with a specific receptor on human premenopausal endometrium: modulating effect of estradiol. Steroids 56:341-346 (1991).
83. Fortunati N, Fissore F, Fazzari A, Berta L, Varvello L, Frairia R. The receptor for sex steroid-binding protein (SBP) of endometrial membranes: solubilization, partial characterization, and role of estradiol in SBP-soluble receptor interaction. Steroids 57:464-470 (1992).
84. Fortunati N, Frairia R, Fissore F, Berta L, Fazzari A, Gaidano G. The receptor for human sex steroid binding protein (SBP) is expressed on membranes of neoplastic endometrium. J Steroid Biochem Mol Biol 42:185-191 (1992).
85. Fortunati N, Fissore F, Fazzari A, Berta L, Benedusi-Pagliano E, Frairia R. Biological relevance of the interaction between sex steroid binding protein and its specific receptor on MCF-7 cells: effect on the estradiol-induced cell proliferation. J Steroid Biochem Mol Biol 45:435-444 (1993).
86. Hryb DJ, Kahn MS, Rosner W. Testosterone-estradiol-binding globulin binds to human prostatic cell membranes. Biochem Biophys Res Commun 128:432-466 (1985).
87. Hryb DJ, Kahn MS, Romas NA, Rosner W. Solubilization and partial characterization of the sex steroid binding globulin receptor from human prostate. J Biol Chem 264:5378-5383 (1989).
88. Hryb DJ, Kahn MS, Romas NA, Rosner W. The control of the interaction of sex hormone-binding globulin with its receptor by steroid hormones. J Biol Chem 265:6048-6054 (1990).
89. Krupenko NT, Awakumov GV, Strel'chyonok OA. Binding of human sex hormone-binding globulin-androgen complexes to the placental synctiotrophoblast membrane. Biochem Biophys Res Commun 71:1279-1283 (1990).
90. Porto CS, Gunsalus GL, Bardin CW, Phillips DM, Musto NA. Receptor-mediated endocytosis of an extracellular steroid-binding protein (TeBG) in MCF-7 human breast cancer cells. Endocrinology 129:436-445 (1991).
91. Strel'chyonok OA, Avvakumov GV, Survilo LI. A recognition system for sex-hormone-binding protein-estradiol complex in human decidua endometrial membranes. Biochim Biophys Acta 802:459-466 (1984).
92. Lewin DL. From outside or in, sex hormones tweak prostate cells. J NIH Res 8:29-30 (1996).
93. Nakhla AM, Kahn MS, Rosner W. Biologically active steroids activate receptor-bound human sex hormone-binding globulin to cause LNCaP cells to accumulate adenosine 3',5'-monophosphate. J Clin Endocrinol Metab 71:398-404 (1990).
94. Nakhla AM, Khan MS, Romas NP, Rosner W. Estradiol causes the rapid accumulation of cAMP in human prostate. Proc Natl Acad Sci 91:5402-5405 (1994).
95. Nakhla AM, Rosner W. Stimulation of prostate cancer growth by androgens and estrogens through the intermediacy of sex hormone-binding globulin. Endocrinology 137:4126-4129 (1996).
96. Laskey J, Berman E. Steroidogenic assessment usine ovary culture in cycling rats: effects of bis(2-diethylhexyl) phthalate on ovarian steroid production. Reprod Toxicol 7:25-33 (1993).
97. Laskey JW, Klinefelter GR, Kelce WR, Ewing LL. Effects of ethane dimethanesulfonate on adult and immature rabbit Leydig cells: comparison with EDS treated rat Leydig cells. Biol Reprod 50:1151-1160 (1994).
98. Eil C, Nisula BC. The binding properties of pyrethroids to human skin fibroblast androgen receptors and to sex hormone binding globulin. J Steroid Biochem 35:409-414 (1990).
99. Hammond GL, Lahteenmaki PLA. A versatile method for the determination of serum cortisol globulin and sex hormone binding globulin binding capacities. Clin Chim Acta 132:101-110 (1983).
100. Wilson EM, French FS. Binding properties of androgen receptors. Evidence for identical receptors in rat testis, epididymis and prostate. J Biol Chem 251:5620-5629 (1976).
101. Damassa DA, Lin T-M, Sonnenschein C, Soto AM. Biological effects of sex hormone-binding globulin on androgen-induced proliferation and androgen metabolism in LNCaP prostate cells. Endocrinology 129:75-84 (1991).
102. Gierthy JF, Lincoln DW, Roth KE, Bowser SS, Bennett JA, Bradley L, Dickerman HW. Estrogen-stimulation of postcon-fluent cell accumulation and foci formation of human MCF-7 breast cancer cells. J Cell Biochem 45:177-187 (1991).
103. Soto AM, Lin T-M, Justicia H, Silvia RM, Sonnenschein C. An "in culture" bioassay to assess the estrogenicity of xenobiotics (E-Screen). Adv Mod Environ Toxicol 21:295-309 (1992).
104. Soto AM, Sonnenschein C, Chung LK, Fernandez MF, Olea N, Olea-Serrano MF. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect 103(Suppl 7):113-122 (1995).
105. Arnold SF, Robinson MK, Notides AC, Guillette LJ Jr., McLachlan JA. A yeast estrogen screen for examining the relative exposure of cells to natural and xenoestrogens. Environ Health Perspect 104:544-548 (1996).
106. Balaguer P, Joyeux A, Denison M, Vincent R, Gillesby B, Zacharewski T. Assessing the estrogenic and dioxin-like activities of chemicals and complex mixtures using in vitro recombinant receptor/reporter gene assays. Can J Physiol Pharmacol 74:216-222 (1996).
107. Connor K, Howell J, Chen I, Liu H, Berhane K, Sciarretta C, Safe S, Zacharewski T. Failure of chloro-5-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro. Fundam Appl Toxicol 30:93-101 (1995).
108. Moore M, Mustain M, Daniel K, Chen I, Safe S, Zacharewski T, Gillesby B, Joyeux A, Balaguer P. Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum. Toxicol Appl Pharmacol 142:160-168 (1997).
109. White R, Jobling S, Hoare SA, Sumpter JP, Parker MG. Environmentally persistant alkylphenolic compounds are estrogenic. Endocrinology 135:175-182 (1994).
110. Zacharewski T, Berhane K, Gillesby B, Burnison K. Detection of estrogen- and dioxin-like activity in pulp and paper mill black liquor effluent using in vitro recombinant receptor/reporter gene assays. Environ Sci Tech 29:2140-2146 (1995).
111. Wiese TE, Kral LG, Dennis KE, Butler WB, Brooks SC. Optimization of estrogen growth response in MCF-7 cells. In Vitro Cell Dev Biol 28A:595-602 (1992).
112. Jobling S, Reynolds T, White R, Parker MG, Sumpter JP. A variety of environmentally persistent chemicals, including some plasticizers, are weakly estrogenic. Environ Health Perspect 103:582-587 (1995).
113. Meek MD, Clemons J, Wu ZF, Zacharewski T. Assessment of the alleged estrogen-receptor mediated activity of eight commercial phthalate esters. Fundam Appl Toxicol 36(Suppl):295 (Abstract 1500) (1997).
114. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, washburn TF, McLachlan JA, Korach KS. Coupling of dual signaling pathways: epidermal growth factor action involves estrogen receptor. Proc Natl Acad Sci USA 89:4658-4662 (1992).
115. Nazareth LV, Weigel NL. Activation of the human androgen receptor through a protein kinase A signaling pathway. J Biol Chem 271:19900-19907 (1996).
116. Mani SK, Allen JM, Clark JH, Blaustein JD, O'Malley BW. Convergent pathways for steroid hormone- and neurotransmitter-induced rat sexual behavior Science 265:1246-1249 (1994). [Published erratum appears in Science (1995) 268:1833].
117. Mani SK, Allen JM, Clark JH, Blaustein JD, O'Malley BW. Convergent pathways for steroid hormone- and neurotransmitter-induced rat sexual behavior Science 265:1246-1249 (1994). [Published erratum appears in Science (1995) 268:1833].
118. Shalev A, Siegrist-Kaiser CA, Yen PM, Wahli W, Burger AG, Chin WW, Meier CA. The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. Endocrinology 137:4499-4502 (1996).
119. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383:728-731 (1996).
120. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930 (1996).
121. Ingraham HA, Lala DS, Ikeda Y, Luo X, Shen WH, Nachtigal MW, Abbud R, Nilson JH, Parker KL. The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev 8:2302-12 (1994).
122. Luo X, Ikeda Y, Schlosser DA, Parker KL. Steroidogenic factor 1 is the essential transcript of the mouse Ftz-F1 gene. Mol Endocrinol 9:1233-9 (1995).
123. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. The nuclear receptor superfamily: the second decade. Cell 83:835-839 (1995).